Immunitas - Company finances
|
EUR
|
2020
From: 2020-01-09
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 34,508 | 55,087 | 87,161 | 124,918 | 115,082 | 120,625 |
| Profit before tax | 3,826 | 1,306 | 7,068 | 63 | 6,248 | 10,125 |
| Net profit | 3,826 | 1,234 | 5,895 | 198 | 4,750 | 8,342 |
| Equity | 7,826 | 9,060 | 14,955 | 15,153 | 14,903 | 18,245 |
| Liabilities | 5,913 | 6,277 | 19,072 | 7,577 | 10,902 | 13,308 |
| Non-current assets | 0 | 0 | 0 | 430 | 0 | 0 |
| Current assets | 13,739 | 15,302 | 33,926 | 22,255 | 25,765 | 31,503 |
| Total assets | 13,739 | 15,302 | 33,926 | 22,685 | 25,765 | 31,503 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 26,938 | 26,462 | 27,501 |
| Social insurance contributions | - | - | - | 5,324 | 5,013 | 4,902 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +59.6% | +58.2% | +43.3% | -7.9% | +4.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 27.8% | 8.1% | 17.4% | 0.9% | 18.4% | 26.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 48.9% | 13.6% | 39.4% | 1.3% | 31.9% | 45.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.1% | 2.2% | 6.8% | 0.2% | 4.1% | 6.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.1% | 2.4% | 8.1% | 0.1% | 5.4% | 8.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 0.7 | 1.3 | 0.5 | 0.7 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,004 | 18,362 | 22,738 | 31,230 | 28,771 | 30,156 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Immunitas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-08-28 | 2025-08-29 | 413.76 |
| 2025-08-19 | 2025-08-21 | 413.76 |
| 2024-01-16 | 2024-01-18 | 586.77 |
| 2022-07-18 | 2022-08-03 | 0.01 |
| 2022-06-16 | 2022-07-04 | 0.01 |
| 2022-05-17 | 2022-06-05 | 0.01 |
| 2022-04-19 | 2022-05-04 | 0.01 |
Immunitas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-24 | 2026-01-24 | 123.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Immunitas, UAB (code 305423459) is a Private Limited Liability Company engaged in the retail sale of other food. In 2025, the company generated revenue of €120.6K, up 4.8% year on year, after €115.1K in 2024 and €124.9K in 2023. This shows a slight recovery in turnover in 2025, although revenue remained below the 2023 level. Net profit improved materially over the period: €198 in 2023, €4.8K in 2024 and €8.3K in 2025. The 2025 profit margin reached 6.9%, compared with 4.1% in 2024 and 0.2% in 2023, indicating stronger operating efficiency and better conversion of sales into earnings. The balance sheet also expanded, with total assets rising to €31.5K in 2025 from €25.8K in 2024 and €22.7K in 2023. Equity increased to €18.2K, while liabilities grew to €13.3K. Key ratios for 2025 point to solid profitability and efficient asset use, including ROE of 45.7%, ROA of 26.5%, debt-to-equity of 0.73 and asset turnover of 3.83x. Revenue per employee was €30.2K.